Search Results from ClinicalConnection

43 studies found

The FINISH Study is a 7-week research study to evaluate the safety of an investigational drug to treat bipolar disorder for children and teens aged 10-17. Those qualified will receive study medicatio...

The FINISH Study is a 7-week research study to evaluate the safety of an investigational drug to treat bipolar disorder for children and teens aged 10-17. Those qualified will receive study medicatio...

The FINISH Study is a 7-week research study to evaluate the safety of an investigational drug to treat bipolar disorder for children and teens aged 10-17. Those qualified will receive study medicatio...

The FINISH Study is a 7-week research study to evaluate the safety of an investigational drug to treat bipolar disorder for children and teens aged 10-17. Those qualified will receive study medicatio...

The FINISH Study is a 7-week research study to evaluate the safety of an investigational drug to treat bipolar disorder for children and teens aged 10-17. Those qualified will receive study medicatio...

The FINISH Study is a 7-week research study to evaluate the safety of an investigational drug to treat bipolar disorder for children and teens aged 10-17. Those qualified will receive study medicatio...

The FINISH Study is a 7-week research study to evaluate the safety of an investigational drug to treat bipolar disorder for children and teens aged 10-17. Those qualified will receive study medicatio...

The FINISH Study is a 7-week research study to evaluate the safety of an investigational drug to treat bipolar disorder for children and teens aged 10-17. Those qualified will receive study medicatio...

The FINISH Study is a 7-week research study to evaluate the safety of an investigational drug to treat bipolar disorder for children and teens aged 10-17. Those qualified will receive study medicatio...

The FINISH Study is a 7-week research study to evaluate the safety of an investigational drug to treat bipolar disorder for children and teens aged 10-17. Those qualified will receive study medicatio...